Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 8 Aug 2009):

Inhibition of platelet-rich arterial thrombus in vivo: acute antithrombotic effect of intravenous HMG-CoA reductase therapy.

Full Abstract

OBJECTIVE: To test the hypothesis that statins will acutely inhibit platelet thrombus formation, intravenous lovastatin was assessed in our well-characterized porcine carotid injury model. METHODS AND RESULTS: The first carotid artery was crush-injured and harvested after 30 minutes. Pigs then received intravenous lovastatin (100 microg/kg bolus+100 microg/kg/h infusion, n=6) or saline (n=11) before injury of the second carotid artery. Thrombus size was quantified by scintillation detection of autologous (111)In-platelets. Sequential carotid injury produced a thrombus more than 50% greater in volume in the second (3149+/-2053 x 10(6)/cm(2)) relative to the first injured artery (2081+/-1552 x 10(6)/cm(2); P=0.04) in control pigs. This augmentation was inhibited by intravenous lovastatin which acutely reduced platelet deposition (944+/-246 x 10(6)/cm(2)) relative to saline control (P=0.02). Flow chamber closure times increased on average by 2.45-fold in response to whole blood lovastatin incubation. Lovastatin (P<0.05) and simvastatin (P<0.05) reduced platelet dense granule secretion in vitro. CONCLUSIONS: Sequential arterial injury augments the thrombotic response suggesting that the propensity for arterial thrombosis is at least partially acquired. This thrombotic augmentation can be acutely attenuated by intravenous lovastatin which may result from a pleiotropic impact on platelet function. These results appear to be a class effect of 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitors.

 

Author information

Author/s: Obi, Chike (C); Wysokinski, Waldemar (W); Karnicki, Krzystof (K); Owen, Whyte G (WG); McBane, Robert D (RD);

Affiliation: University of Pittsburgh School of Medicine, Pittsburgh, Penn., USA.

Journal and publication information

Publication Type: Journal Article

Journal: Arteriosclerosis, thrombosis, and vascular biology (Arterioscler Thromb Vasc Biol), published in United States. (Language: eng)

Reference: 2009-Sep; vol 29 (issue 9) : pp 1271-6

Dates: Created 2009/08/20; Completed 2009/09/08;

PMID: 19667107, status: MEDLINE (last retrieval date: 9/8/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: Hydroxymethylglutaryl-CoA Reductase Inhibitors (0) ; Lovastatin (75330-75-5)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

1/30/1999
8/17/2008
Higher Relevance Score (100)
Lower Relevance Score (75)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy LLC 2003-2009 - All rights reserved. Terms of Use | Contact Us | Index